Picture of Generation Bio logo

GBIO — Generation Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Generation Bio Co reports results for the quarter ended in September - Earnings Summary

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted loss
of 56 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 56 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Generation Bio Co's reported EPS for the quarter was a loss
of 56 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Generation Bio Co shares had fallen by 14.2% this quarter and
lost 24.2% so far this year.
* The company reported a quarterly loss of $31.86 million.
* Wall Street's median 12-month price target for Generation Bio
Co is $38.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 12:11 a.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Generation Bio

See all news